Journal of Neural Transmission

, 114:195 | Cite as

Postnatal iron overload destroys NA-DA functional interactions

  • A. Fredriksson
  • T. Archer


C57/BL6 mice were administered either postnatal iron (Fe2+ 7.5 mg/kg, on postnatal days 10–12) or vehicle, followed by administration of either DSP4 (50 mg/kg, s.c., 30 min after injection of zimeldine, 20 mg/kg, s.c.) or vehicle (saline) at 63 days of age. Three weeks later, iron/vehicle treated, DSP4/vehicle treated mice were injected with either a low dose of MPTP (2 × 20 mg/kg, with a 24-hr interval between injections) or vehicle. Behaviour testing took place a further three weeks (spontaneous behaviour and L-Dopa induced) and two weeks (clonidine-L-Dopa induced) later. Postnatal iron administration exacerbated the bradykinesia induced by MPTP and virtually abolished all spontaneous motor activity in NA-denervated mice that were MPTP-treated. Postnatal iron administration reduced markedly the restoration of motor activity by suprathreshold L-Dopa (20 mg/kg) following a 60-min habituation to the test chambers. Pretreatment with DSP4 effectively eliminated the restorative effect of L-Dopa in the MPTP mice. The synergistic effects of co-administration of clinidine (1 mg/kg) with a subthreshold dose of L-Dopa (5 mg/kg) in elevating the motor activity of MPTP mice were reduced markedly by postnatal iron administration, as well as by pretreatment with DSP4. NA-denervation by DSP4, after postnatal iron treatment, totally abolished the activity-elevating effects of the α-adrenoceptor agonist + DA-precursor combination in MPTP mice, and virtually eliminated these effects in saline (non-MPTP) mice.

Postnatal iron administration caused enduring higher levels of total iron content in all the groups with an increased level in mice treated with DSP4 followed by MPTP. These divergent findings confirm the direct influence of NA innervation upon dopaminergic functional expression and indicate a permanent vulnerability both in the noradrenergic and dopaminergic pathways following the postnatal infliction of an iron overload.

Keywords: Postnatal iron, DSP4, MPTP, vehicle, motor deficits, locomotion, rearing, total activity, suprathreshold L-Dopa, restoration, clonidine, subthreshold L-Dopa, denervation, DA, NA, C57/BL6 mice, PD 


  1. Archer, T 1982Serotonin and fear retention in the ratJ Comp Physiol Psychol96491516PubMedCrossRefGoogle Scholar
  2. Archer, T, Fredriksson, A 2000Effects of clonidine and adrenoceptor antagonists on motor activity in DSP4-treated mice I: dose, time- and parameter-dependencyNeurotoxicity Res1235247Google Scholar
  3. Archer, T, Fredriksson, A 2001Effects of α-adrenoceptor agonists in chronic morphine administered DSP4-treated rats: evidence for functional cross-sensitizationNeurotoxicity Res3411432CrossRefGoogle Scholar
  4. Archer, T, Fredriksson, A 2003An antihypokinesic action of α2-adrenoceptors upon MPTP-induced behaviour deficits in miceJ Neural Transm110183200PubMedCrossRefGoogle Scholar
  5. Archer T, Fredriksson A (2006) Influence of noradrenaline denervation on MPTP-induced deficits in mice. J Neural Transm (in press)Google Scholar
  6. Archer, T, Ögren, S-O, Johansson, G, Ross, SB 1982DSP4-induced two-way active avoidance impairment: involvement of central and not peripheral noradrenaline depletionPsychopharmacology76303309PubMedCrossRefGoogle Scholar
  7. Archer, T, Mohammed, AK, Ross, SB, Söderberg, U 1983T-maze learning, spontaneous activity and food intake recovery following systemic administration of the noradrenaline neurotoxin, DSP4Pharmacol Biochem Behav19121130PubMedCrossRefGoogle Scholar
  8. Archer, T, Jonsson, G, Ross, SB 1984A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurons in the CNS of the ratBr J Pharmacol82249257PubMedGoogle Scholar
  9. Archer, T, Jonsson, G, Ross, SB 1985Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamineBehav Neural Biol43238249PubMedCrossRefGoogle Scholar
  10. Archer, T, Fredriksson, A, Jonsson, G, Lewander, T, Mohammed, AK, Ross, SB, Soderberg, U 1986aCentral noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the ratPsychopharmacology88141146CrossRefGoogle Scholar
  11. Archer, T, Jonsson, G, Minor, BG, Post, C 1986bNoradrenergic-serotonergic interactions and nociception in the ratEurop J Pharmacol120295307CrossRefGoogle Scholar
  12. Dooley, DJ, Bittiger, H, Hauser, KL, Bischoff, SL, Waldmeier, PC 1983aAlteration of central alpha 2- and beta-adrenergic receptors in the rat after DSP4, a selective noradrenergic neurotoxinNeuroscience9889898CrossRefGoogle Scholar
  13. Dooley, DJ, Mogilnicka, E, Delini-Stula, A, Waechter, F, Truog, A, Wood, J 1983bFunctional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxinPsychopharmacology8115CrossRefGoogle Scholar
  14. Fornai, F, Bassi, L, Torracca, MT, Alessandri, MG, Scalori, V, Corsini, GU 1996Region- and neurotransmitter-dependent species and strain differences in DSP4-induced monoamine depletion in rodentsNeurodegeneration5241249PubMedCrossRefGoogle Scholar
  15. Fornai, F, Alessandri, MG, Torracca, MT, Bassi, L, Corsini, GU 1997Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletionsJ Pharmacol Exp Ther283100107PubMedGoogle Scholar
  16. Fredriksson, A, Archer, T 1994MPTP-induced behavioural and biochemi_cal deficits: a parametric analysisJ Neural Transm Park Dis Dement Sect7123132PubMedCrossRefGoogle Scholar
  17. Fredriksson, A, Archer, T 2000Effects of clonidine and α-adrenoceptor antagonists on motor activity in DSP4-treated mice II: interactions with apomorphineNeurotoxicity Res1249259CrossRefGoogle Scholar
  18. Fredriksson, A, Archer, T 2003Effect of postnatal iron administration on MPTP-induced behavioural deficits and neurotoxicity: behavioural enhancement by L-Dopa-MK-801 co-administrationBehav Brain Res1393146PubMedCrossRefGoogle Scholar
  19. Fredriksson, A, Plaznik, A, Sundström, E, Jonsson, G, Archer, T 1990MPTP-induced hypoactivity in mice: reversal by L-DopaPharmacol Toxicol67295301PubMedCrossRefGoogle Scholar
  20. Fredriksson, A, Palomo, T, Chase, TN, Archer, T 1999Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonistsJ Neural Transm106283300PubMedCrossRefGoogle Scholar
  21. Fredriksson, A, Schroder, N, Eriksson, P, Izquierdo, I, Archer, T 2001Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficitsParkinsonism Relat D797105CrossRefGoogle Scholar
  22. Glowinski, J, Iversen, LL 1966Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brainJ Neurochem13655669PubMedCrossRefGoogle Scholar
  23. Heal, DJ, Butler, SA, Prow, MR, Buckett, WR 1993Quantification of alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioningEurop J Pharmacol2493741CrossRefGoogle Scholar
  24. Heikkila, RE, Sieber, B-A, Manzino, L, Sonsalla, PK 1989Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouseMol Chem Neuropathol10171183PubMedCrossRefGoogle Scholar
  25. Jonsson, G, Hallman, H 1982Response of central monoamine neurons following an early neurotoxic lesionBibl Anat237692PubMedGoogle Scholar
  26. Jonsson, G, Hallman, H, Ponzio, F, Ross, SB 1981DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine) – a useful denervation tool for central and peripheral noradrenaline neuronsEurop J Pharmacol72173188CrossRefGoogle Scholar
  27. Jonsson, G, Hallman, H, Sundström, E 1982Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the ratNeuroscience728952907PubMedCrossRefGoogle Scholar
  28. Kirk, R 1995Experimental design: procedures for the behavioural sciencesBrooks/ColeBelmont, CalifGoogle Scholar
  29. Langston, JW 1985MPTP neurotoxicity: an overview and characterization of phases of toxicityLife Sci36201206PubMedCrossRefGoogle Scholar
  30. Latigan, AJ, Marien, MR, Colpaert, FC 1992Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis studyLife Sci50995999CrossRefGoogle Scholar
  31. Marien, MR, Briley, M, Colpaert, FC 1993Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in miceEurop J Pharmacol236487489CrossRefGoogle Scholar
  32. Marien, MR, Colpaert, FC, Rosenquist, AC 2004Noradrenergic mechanisms in neurodegenerative diseases: a theoryBrain Res Rev453878PubMedCrossRefGoogle Scholar
  33. Nishi, K, Kondo, T, Narabayashi, H 1991Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopaNeurosci Lett123244247PubMedCrossRefGoogle Scholar
  34. Ponzio, F, Hallman, H, Jonsson, G 1981Noradrenaline and dopamine interaction in rat brain during developmentMed Biol59161169PubMedGoogle Scholar
  35. Post, C, Persson, ML, Archer, T, Minor, BG, Danysz, W, Sundström, E 1987Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletionEurop J Pharmacol137107116CrossRefGoogle Scholar
  36. Riekkinen, M, Kejonen, K,  et al. 1998Reduction of noradrenaline impairs attention and dopamine depletion slows response in Parkinson’s diseaseEurop J Neurosci1014291435CrossRefGoogle Scholar
  37. Ross, SB 1976Long-term effects of N-2-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heartBrit J Pharmacol58521527Google Scholar
  38. Ross, SB, Renyi, L 1976On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on the active uptake of noradrenalineJ Pharmacol Pharmac28458459Google Scholar
  39. Sonsalla, PK, Heikkila, RE 1986The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in miceEurop J Pharmacol129339345CrossRefGoogle Scholar
  40. Sundström, E, Fredriksson, A, Archer, T 1990Chronic neurochemical and behavioural changes in MPTP-lesioned C57 Bl/6 mice: a model for Parkinson’s diseaseBrain Res528181188PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • A. Fredriksson
    • 1
  • T. Archer
    • 2
    • 3
  1. 1.Department of Neuroscience, Psychiatry UlleråkerUniversity of UppsalaUppsalaSweden
  2. 2.Department of PsychologyUniversity of GöteborgGöteborgSweden
  3. 3.University of KalmarKalmarSweden

Personalised recommendations